Previous 10 | Next 10 |
MIRAMAR, Fla., May 02, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) is pleased to announce that their wholly-owned subsidiary NuGenerex Diagnostics LLC, ( www.nugenerexdiangostics.com ) has filled ...
MIRAMAR, Florida , April 29, 2019 /PRNewswire/ -- Launch of ExcellagenÒ for Wound Healing by subsidiary Olaregen Therapeutix Pending completion of acquisitions: Pantheon Medical, MediSource Partners, and Fuse Medical, Financing initiatives S1 Filing Applicati...
Inventor Dr. Lois Chandler, PhD Presents Excellagen® Clinical Trial Data Demonstrating Rapid Healing of Diabetic Neuropathic Foot Ulcers MIRAMAR, FL, April 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www...
DALLAS, April 09, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced an online presentation scheduled next week for Wednesday, April 17 th , where management will provide details on its pa...
Sales & Marketing Executive Brings Global Expertise in Global Channel Marketing MIRAMAR, FL, April 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnology Corporation ( www.generex.com ) (OTCQB: GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) is pr...
MIRAMAR, FL, April 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Generex would like to clarify the discussions surrounding the filed 10-Q ending the period of January 31, 2019, or the second quarter, filed on March 25, 2019, and its subsequent non-reliance 8-K filed on March 28, 2019. ...
Generex and Veneto Holdings Re-Negotiate Acquisition from a $35 Million Total Consideration to a $21 Million Stock-Only Transaction at $2.50 Per Share to Satisfy Generex’ Obligations MIRAMAR, FL, March 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnolo...
Excellagen Clinical Trial Analysis: Rapid Healing of Diabetic Neuropathic Foot Ulcers Presentation on Friday Evening April 5, 2019 at the JW Marriott Hotel in Washington, DC MIRAMAR, FL, March 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnol...
DALLAS, March 22, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- North American Cannabis Holdings, Inc. (USOTC: USMJ) (“USMJ”) and Puration Inc. (USOTC: PURA) (“PURA”) today published an update on the progress the two companies are making toward their respective pla...
DALLAS, March 20, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced the company plans to publish its phase one research on the pilot treatment of Chronic Obstructive Pulmonary...
News, Short Squeeze, Breakout and More Instantly...
Generex Biotechnology Company Name:
GNBT Stock Symbol:
OTCMKTS Market:
Generex Biotechnology Website:
MIRAMAR, Fla., July 26, 2021 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) subsidiary Olaregen Therapeutix announced in May that the company has executed a Distribution Agreement with Nexgen Medical Sdn Bhd, Inc. (“Nexgen”) to be Ge...
Ii-Key Immunotherapeutic Vaccine Technology Ii-Key-SARS-CoV-2 Vaccine Market Potential & International Contracts Market Potential for AE37 (Ii-Key-HER2) Immunotherapeutic Vaccine for breast, prostate, and bladder cancers MIRAMAR, Fla., June 22, 2021 (GLOBE NEWSWIRE) --...
NuGenHealth Software as a Service (SaaS) platform that enables their clients to monitor the health and wellbeing of their patient population. Westside Medicine & Cardiology, Inc. is a professional corporation that engages medical providers who are duly licensed in Ohio ...